Navigation Links
HPV Data May Aid Vaccine's Effectiveness
Date:3/24/2009

Most cervical cancers arose from strains covered by the shot, study finds

TUESDAY, March 24 (HealthDay News) -- The majority of invasive cervical cancers in New Mexico in the 1980s and 1990s contained DNA from human papillomavirus type 16 (HPV16) and HPV type 18 (HPV18), says a new study.

It also found that women diagnosed with HPV16- or HPV18-positive cancers were an average of five years younger than those diagnosed with cancers associated with other HPV types.

The HPV vaccine (Gardasil) protects against infections caused by HPV16 and HPV18, so the new findings may have implications for future cancer screening programs, the researchers said.

The researchers analyzed U.S. data in the Surveillance, Epidemiology and End Results registry and identified 1,213 cases of in situ cervical cancer diagnosed between 1980 and 1999, as well as 808 cases of invasive cervical cancer diagnosed between 1980 and 1999 in New Mexico.

HPV16 DNA was found in 53.2 percent of invasive cervical cancers, HPV18 DNA was found in 13.1 percent, and HPV45 DNA in 6.1 percent. HPV16 DNA was found in 56.3 percent of in situ cervical cancers, HPV31 DNA in 12.6 percent, and HPV33 DNA in 8 percent.

Patients' median age at diagnosis of invasive cancer with HPV16 and HPV18 was 48.1 years, and 45.9 years, respectively. Median age at diagnosis of invasive cancer with other HPV genotypes was 52.3 years.

The study is in the March 24 online issue of the Journal of the National Cancer Institute.

"To our knowledge, this is the largest study of its kind conducted in a U.S. population," wrote a team led by Cosette M. Wheeler, of the University of New Mexico Health Sciences Center in Albuquerque.

"This study of HPV genotypes in New Mexico provides important baseline data for evaluating the effectiveness of nearly implemented HPV-based technologies, HPV vaccines, and HPV screening in the prevention of cervical cancer," she said. "Moreover, these data can guide the future application of these technologies to maximize the cost-effective, public health benefits of these interventions."

More information

The U.S. Food and Drug Administration has more about HPV.



-- Robert Preidt



SOURCE: Journal of the National Cancer Institute, news release, March 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Saving Vaccines with SensoTech's Breakthrough in Vaccine Temperature Monitoring
2. Better by design: Engineering flu vaccines
3. Information Parents Need on Vaccines and Their Childs Health
4. NBA and WNBA Help Teens Take Their Best Shot at Health With New Vaccines for Teens Educational Campaign
5. Federal Court Declares Vaccines Do Not Cause Autism
6. New test may help to ensure that dengue vaccines do no harm
7. Novel Vaccines Improve Potential for European Vaccines Manufacturers
8. Barrs BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA
9. 109 Medicines and Vaccines Now in Development for HIV/AIDS
10. Researchers discover strategy for predicting the immunity of vaccines
11. Medical societies: Adults need vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HPV Data May Aid Vaccine's Effectiveness 
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... solution provider of enterprise software products, today announced a strategic partnership with ... Blue users to access and analyze their Fusion platform for building powerful enterprise ...
(Date:1/24/2017)... California (PRWEB) , ... January 24, 2017 , ... i2i ... McNamara as chief financial officer. , “Cary’s broad financial background is ... possesses both the strategic planning and day-to-day financial operations skills we need to take ...
(Date:1/24/2017)... ... 24, 2017 , ... The Cruise Web Inc. was recognized today ... 4th Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships ... year based on overall business growth in revenue and guests and continuous partnership support ...
(Date:1/24/2017)... ... January 24, 2017 , ... Twelve startups have ... the 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under Armour Founder and CEO ... entrepreneurs will showcase their businesses on February 6, 2017, at Under Armour’s global ...
(Date:1/24/2017)... ... January 24, 2017 , ... West’s ... its annual Solutions Series of webinars will start January 31 with a session ... number of current health and benefits topics, including employee engagement, pricing transparency, population ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... , Jan. 24, 2017 Asia-Pacific Bone ... GlobalData,s new report, "Asia-Pacific Bone Densitometers Market Outlook ... Asia-Pacific Bone Densitometers market. The report provides value, ... and average prices (USD) within market segements - ... (QUS). The report also provides company shares ...
(Date:1/24/2017)... GREENVILLE, S.C. , Jan. 24, 2017 ... plans to release its fiscal 2017 first quarter results ... regular trading. The company will conduct a ... 3, to review the company,s financial and operating results for ... of the conference call will be available online at ...
(Date:1/24/2017)... , Jan. 24, 2017  In a ... Hospital Muenster, Germany 1 ... and FDA cleared NephroCheck® Test identified patients at ... open heart surgery. In this randomized control trial ... patients identified received either the institution,s standard of ...
Breaking Medicine Technology: